Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) targeting central nervous system disorders. Its structural features allow for favorable binding to specific receptors, making it valuable in drug discovery for psychiatric and neurological conditions. The compound is also utilized in the preparation of novel kinase inhibitors and has shown utility in enhancing the pharmacokinetic properties of drug candidates, such as improving metabolic stability and blood-brain barrier penetration. Its incorporation into molecular scaffolds helps modulate solubility and bioavailability in advanced therapeutic agents.